Targeting of Topoisomerase I for Prognoses and Therapeutics of Camptothecin-Resistant Ovarian Cancer

DNA topoisomerase I (TOP1) levels of several human neoplasms are higher than those of normal tissues. TOP1 inhibitors are widely used in treating conventional therapy-resistant ovarian cancers. However, patients may develop resistance to TOP1 inhibitors, hampering chemotherapy success. In this study...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Yu-Chieh, Lee, Chii-Hong, Tsai, Hsiang-Ping, An, Herng-Wei, Lee, Chi-Ming, Wu, Jen-Chine, Chen, Chien-Shu, Huang, Shih-Hao, Hwang, Jaulang, Cheng, Kur-Ta, Leiw, Phui-Ly, Chen, Chi-Long, Lin, Chun-Mao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514822/
https://www.ncbi.nlm.nih.gov/pubmed/26207989
http://dx.doi.org/10.1371/journal.pone.0132579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514822/
https://www.ncbi.nlm.nih.gov/pubmed/26207989
http://dx.doi.org/10.1371/journal.pone.0132579

Ejemplares similares